Upstream Processing Capability
Our suite of next generation high throughput technologies will rapidly determine the optimal parameters for upscaling your process. One of the many examples is the ambr® 250 bioreactor system, which:
- Is suitable for mammalian and microbial processes
- Provides a body of evidence for presentation to investors and regulators to support your process development pathway
- Minimises the total number of experiments typically required for process development, with the associated cost savings, while generating more comprehensive data sets.